Global biophotonics industry expected to reach $80 billion by 2027 | New

DUBLIN, June 16, 2022 /PRNewswire/ — The “Global Biophotonics Market (2022-2027) by Technology, Application, End-Use, Geography, Competitive Analysis and Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.comit is offer.

The global biophotonics market is estimated at $51.45 billion in 2022 and should reach $80 billion by 2027, growing at a CAGR of 9.23%.

Market dynamics are forces that impact pricing and stakeholder behaviors in the global Biophotonics market. These forces create price signals that result from changes in the supply and demand curves for a given product or service. The forces of market dynamics can be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand and supply. Human emotions can also drive decisions, influence the market and create price signals.

As market dynamics impact supply and demand curves, policymakers aim to determine how best to use various financial tools to stem various strategies aimed at accelerating growth and reducing risk.

Company Profiles

The report provides a detailed analysis of competitors in the market. It covers the analysis of financial performance of listed companies in the market. The report also offers detailed information about recent development and competitive scenario of the companies. Some of the companies covered in this report are Affymetrix Inc, Andor Technology Ltd, Becton Dickinson And Company, Carl Zeiss AG, FEI Company, General Electric Company, Glenbrook Technologies Inc, etc.

Countries studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United StatesRest of the Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Swiss, UKRest of Europe)
  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emiratesrest of the MEA)
  • Asia Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, TaiwanRest of Asia Pacific)

Competitive quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and assess the position of companies based on their industry position score and market performance score. The tool uses various factors to classify players into four categories. Some of these factors considered for analysis are financial performance over the past 3 years, growth strategies, innovation score, new product launches, investments, market share growth, etc

Ansoff analysis

The report presents a detailed analysis of the Ansoff matrix for the global biophotonics market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design business growth strategies. The matrix can be used to assess approaches in four strategies viz. Market development, market penetration, product development and diversification. The matrix is ​​also used for risk analysis to understand the risk associated with each approach.

The analyst analyzes the global biophotonics market using the Ansoff Matrix to provide the best approaches a company can take to improve its position in the market.

Based on the SWOT analysis done on the industry and industry players, the analyst has designed appropriate strategies for market growth.

Why buy this report?

  • The report offers a comprehensive assessment of the global biophotonics market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and market size projections. Projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The main research is done through interviews, surveys and observations of renowned personnel in the industry.
  • The report includes in-depth market analysis using Porter’s 5 forces model and Ansoff’s matrix. Additionally, the impact of Covid-19 on the market is also presented in the report.
  • The report also includes the regulatory scenario in the industry, which will help you to make an informed decision. The report discusses the major regulatory bodies and major rules and regulations imposed on this industry across various geographies.
  • The report also contains competitive analysis using Positioning Quadrants, the analyst’s proprietary competitive positioning tool.

Main topics covered:

1 Description of the report

2 Research methodology

3 Executive summary

4 Market dynamics

4.1 Drivers

4.1.1 Growing Demand for Home POC Devices

4.1.2 The emergence of nanotechnology in biophotonics

4.1.3 Aging Population and Rise in Lifestyle-Related Diseases

4.2 Constraints

4.2.1 Technical problems and high cost

4.3 Opportunities

4.3.1 Increased investment in R&D on biophotonics

4.3.2 Growing Use of Biophotonics Across Multiple Industries

4.4 Challenges

4.4.1 Slow rate of commercialization

5 Market Analysis

5.1 Regulatory scenario

5.2 Porter’s Five Forces Analysis

5.3 Impact of COVID-19

5.4 Ansoff matrix analysis

6 Global Biophotonics Market, By Technology

6.1 Presentation

6.2 In vivo

6.3 In Vitro

7 Global Biophotonics Market, by Application

7.1 Presentation

7.2 Transparent imaging

7.3 Internal imaging (endoscopy)

7.4 Molecular Spectro

7.5 Surface imaging

7.6 Microscopy

7.7 Light therapy

7.8 Biosensors

8 Global Biophotonics Market, By End Use

8.1 Presentation

8.2 Medical diagnosis

8.3 Medical therapy

8.4 Non-medical request

Global 9 Americas Biophotonics Market

9.1 Presentation

9.2 Argentina

9.3 Brazil

9.4 Canada

9.5 Chile

9.6 Colombia

9.7 Mexico

9.8 Peru

9.9 United States

9.10 Rest of the Americas

ten Europe Global biophotonics market

10.1 Presentation

10.2 Austria

10.3 Belgium

10.4 Denmark

10.5 Finland

10.6 France

10.7 Germany

10.8 Italy

10.9 Netherlands

10.10 Norway

10.11 Poland

10.12 Russia

10.13 Spain

10.14 Sweden

10:15 a.m. Swiss

10.16 UK

10.17 Rest of Europe

11 Middle East and africa Global biophotonics market

11.1 Presentation

11.2 Egypt

11.3 Israel

11.4 Qatar

11.5 Saudi Arabia

11.6 South Africa

11.7 United Arab Emirates

11.8 Rest of MEA

12 Global Biophotonics Market in APAC

12.1 Presentation

12.2 Australia

12.3 Bangladesh

12.4 China

12.5 India

12.6 Indonesia

12.7 Japan

12.8 Malaysia

12.9 Philippines

12.10 Singapore

12.11 South Korea

12.12 Sri Lanka

12.13 Thailand

12.14 Taiwan

12.15 Rest of Asia Pacific

13 Competitive Landscape

13.1 Competitive Quadrant

13.2 Market Share Analysis

13.3 Strategic Initiatives

13.3.1M&A and investments

13.3.2 Partnerships and collaborations

13.3.3 Product Developments and Improvements

14 company profiles

14.1 Affymetrix Inc.

14.2 Andor Technology Ltd

14.3 Becton Dickinson and company

14.4 Carl Zeiss AG

14.5 FEI Company

14.6 General electricity company

14.7 Glenbrook Technologies Inc.

14.8 Hamamatsu Photonics KK

14.9 Horiba Ltd

14.10 IPG Photonics Corp

14.11 Lumenis SA

14.12 Olympus Company

14.13 OpGen

14.14 Oxford Technologies

14.15 PerkinElmer Inc.

14.16 Koninklijke Philips NV

14.17 Precision Photonics Corp.

14.18 The Procter & Gamble Company

14.19 F. Hoffmann-La Roche SA

14.20 Thermo Fisher Scientific Inc.

14.21 Toshiba Corp.

14.22 Zecotek Photonics Inc.

14.23 Zenalux Biomedical Inc.

15 Appendix

For more information on this report, visit

Media Contact:

Research and Markets

Laura Woodsenior

[email protected]

For EST office hours, call +1-917-300-0470

For USA/CAN call toll free +1-800-526-8630

For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904

Fax (outside the US): +353-1-481-1716

Show original content:

SOURCE Research and Markets

Previous Wall Street banks raise prime rates to match Fed hike
Next Oppo teams up with Ericsson and Qualcomm to roll out 5G enterprise network slicing, Telecom News, ET Telecom